4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-046481
Chief Financial Officer sold 20,000 shares at $37.78 ($755,600)
- Chief Financial Officer acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2020-08-10 | Option exercise | +20,000 | $6.32 | $126,400 | 21,000 | D: show line 1 in the form |
| Cohen Chad M Chief Financial Officer | 2020-08-10 | Sale | −20,000 | $37.78 | $755,600 | 1,000 | D: show line 2 in the form |
| Open-market sales · 20,000 sh · avg $37.78 · $755,600 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2020-08-10 | Option exercise · Stock Option (Right To Buy) | −20,000 | 620,000 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…